25I-NBOH
25I-NBOH[edit]
25I-NBOH, also known as 2C-I-NBOH, is a potent psychedelic compound that belongs to the N-benzylphenethylamine class. It is a derivative of the phenethylamine 2C-I and is closely related to the NBOMe series of compounds. 25I-NBOH is known for its strong binding affinity to the 5-HT2A receptor, which is believed to be responsible for its psychedelic effects.
Chemical Structure[edit]
25I-NBOH is chemically similar to 2C-I, with the addition of a 2-hydroxybenzyl group attached to the nitrogen atom of the phenethylamine backbone. This modification increases its potency and alters its pharmacological profile compared to its parent compound, 2C-I.
Pharmacology[edit]
The primary mechanism of action for 25I-NBOH is its agonistic activity at the 5-HT2A receptor, a subtype of the serotonin receptor that is implicated in the modulation of mood, perception, and cognition. The compound's high affinity for this receptor is thought to underlie its psychedelic effects, which can include altered visual and auditory perceptions, changes in thought patterns, and emotional experiences.
Effects[edit]
The effects of 25I-NBOH are similar to those of other psychedelics, such as LSD and psilocybin. Users may experience visual hallucinations, synesthesia, and a distorted sense of time. The intensity and duration of these effects can vary depending on the dose and individual sensitivity.
Safety and Toxicity[edit]
As with many research chemicals, the safety profile of 25I-NBOH is not well-established. There have been reports of adverse effects, including vasoconstriction, tachycardia, and hypertension, particularly at higher doses. Due to its potency and the potential for overdose, caution is advised when handling this compound.
Legal Status[edit]
The legal status of 25I-NBOH varies by country. In some jurisdictions, it is classified as a controlled substance, while in others, it may be legal or unregulated. It is important to be aware of the local laws regarding the possession and use of this compound.
Related Compounds[edit]
See Also[edit]
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
